Tradestie Institutional Equity Comparison Engine

DCTH vs CVM โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

DCTH Overall Edge

DCTH Captures Institutional Edge (3โ€“1 Pillars ยท 6โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Delcath Systems Inc (DCTH) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while CVM counters with relative strength in Valuation. Fundamentally, DCTH trades at N/M Forward P/E with 5.2% operating margin (+70.7% YoY revenue) versus CVM at 23.0x Forward P/E and 0.0% operating margin (-62.7% YoY). In options structure, DCTH sits in BREAKOUT (43rd %ile IV; Dealer Gamma Walls on Pro) against CVM sits in BREAKDOWN (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner CVM
DCTH N/M vs CVM 23.0x Fwd P/E
Growth & Margin Winner DCTH
Op Margin 5.2% vs 0.0% ยท YoY +70.7% vs -62.7%
Momentum & Technical Winner DCTH
1Y +128.6% vs -77.5% ยท 52W Pos 80% vs 10%
Options & Structure Winner DCTH
BREAKOUT (43rd %ile IV) vs BREAKDOWN (N/A IV)
DCTH NASDAQ
Delcath Systems Inc
Surgical & Medical Instruments & Apparatus
$19.68
-4.23% 1D
Market Cap $743.8M
1M Return +39.77%
1Y Return +128.57%
Forward P/E N/M
Unified AI Score
35.9 / 100 SELL
Tech 50.0 Fund 38.0 Flow 60.0 Mom 54.0
CVM NYSE American
Cel-Sci Corporation
Biological Products, (No Disgnostic Substances)
$1.59
+24.22% 1D
Market Cap $20.9M
1M Return -11.17%
1Y Return -77.48%
Forward P/E 23.0x
Unified AI Score
56.6 / 100 HOLD
Tech 60.0 Fund 54.0 Flow 50.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: DCTH +128.57% CVM -77.48% Spread: +196.36 pp (DCTH Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period DCTH Revenue CVM Revenue DCTH Op. Margin CVM Op. Margin Margin Edge
FY2013 $0M $0M -4179.6% -12450.1% DCTH
FY2014 $0M $0M -1805.8% -9721.4% DCTH
FY2015 $0M N/A -870.6% N/A DCTH
FY2021 $0M N/A -690.0% N/A DCTH
FY2022 $0M N/A -1245.1% N/A DCTH
FY2023 $0M N/A -1849.0% N/A DCTH
FY2024 $40M N/A -33.4% N/A DCTH
FY2025 $90M N/A 0.8% N/A DCTH

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: DCTH (6) vs CVM (4)
Institutional Metric DCTH CVM Criterion Row Winner
Market Capitalization Scale $743.8M $20.9M Larger Scale DCTH
Trailing P/E Ratio Valuation 133.6x 23.0x Lower Multiple CVM
Forward P/E Ratio Valuation N/M 23.0x Lower Multiple CVM
Revenue Growth (YoY) Growth +70.7% -62.7% Higher Growth DCTH
Operating Margin (TTM) Profitability 5.2% 0.0% Higher Margin DCTH
Net Profit Margin Profitability 6.0% 0.0% Higher Margin DCTH
Return on Equity (ROE) Capital Efficiency 5.4% -252.5% Higher ROE DCTH
52-Week Range Position Momentum 80% ($8โ€“$23) 10% ($1โ€“$8) Stronger Trend DCTH
Beta / 30D Volatility Risk Regime 1.63ฮฒ ยท 131% Vol 0.65ฮฒ ยท 120% Vol Lower Realized Risk CVM
Unified Institutional Score Composite Signal 35.9 / 100 (SELL) 56.6 / 100 (HOLD) Higher Composite CVM

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full DCTH vs CVM Buy Guide
DCTH BREAKOUT
66d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 43rd %ile
IV Regime Balanced (25thโ€“60th %ile)
Live DCTH Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
CVM BREAKDOWN
29d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live CVM Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither DCTH nor CVM registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.